CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $59,000 | +490.0% | 73,117 | +1571.6% | 0.00% | – |
| Q1 2021 | $10,000 | -71.4% | 4,374 | -62.9% | 0.00% | – |
| Q4 2020 | $35,000 | +600.0% | 11,781 | +271.1% | 0.00% | – |
| Q3 2020 | $5,000 | -72.2% | 3,175 | -57.0% | 0.00% | – |
| Q2 2020 | $18,000 | -35.7% | 7,385 | -46.0% | 0.00% | – |
| Q1 2020 | $28,000 | -9.7% | 13,674 | +35.3% | 0.00% | – |
| Q4 2019 | $31,000 | +34.8% | 10,108 | +46.6% | 0.00% | – |
| Q3 2019 | $23,000 | -48.9% | 6,893 | -50.8% | 0.00% | – |
| Q2 2019 | $45,000 | +18.4% | 14,008 | +4.5% | 0.00% | – |
| Q1 2019 | $38,000 | -24.0% | 13,408 | +9.7% | 0.00% | – |
| Q4 2018 | $50,000 | -21.9% | 12,223 | -10.8% | 0.00% | – |
| Q3 2018 | $64,000 | +433.3% | 13,700 | +19.1% | 0.00% | – |
| Q3 2015 | $12,000 | -42.9% | 11,499 | 0.0% | 0.00% | – |
| Q2 2015 | $21,000 | +23.5% | 11,499 | 0.0% | 0.00% | – |
| Q1 2015 | $17,000 | +13.3% | 11,499 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | -28.6% | 11,499 | 0.0% | 0.00% | – |
| Q3 2014 | $21,000 | – | 11,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
| Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
| Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
| Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
| Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
| Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
| FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
| Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
| RBF Capital, LLC | 159,367 | $127,000 | 0.01% |